FdaApplication
NDA 021447
Identifiers
- fda_app_no: NDA021447
Properties
| Property | Value |
|---|---|
| applicant_name | LEGACY PHARMA INC SEZC |
| application_type | NDA |
| approval_date | 2002-08-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 4MG BASE | CAPSULE;ORAL |
| ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 6MG BASE | CAPSULE;ORAL |
| ZANAFLEX | TIZANIDINE HYDROCHLORIDE | EQ 2MG BASE | CAPSULE;ORAL |
3 products